FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - BOERSE MUENCHEN 20:45:37 31/05/2024 BST | ||
| 9.46 EUR | -7.44% |
|
| 1 month | -16.21% | ||
| 3 months | -15.46% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 9.46 | -7.44% |
| 30/05/24 | 10.22 | -6.15% |
| 29/05/24 | 10.89 | +4.41% |
| 28/05/24 | 10.43 | +0.10% |
| 27/05/24 | 10.42 | -.--% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 08:45 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD36C2 |
| ISIN | DE000HD36C20 |
| Date issued | 28/02/2024 |
| Strike | 293.4 $ |
| Maturity | Unlimited |
| Parity | 7.05 : 1 |
| Emission price | 10.59 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.49 € |
|---|---|
| Lowest since issue | 8.29 € |
| Spread | 0.03 € |
| Spread % | 0.32% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
224.9
USD
Average target price
284.8
USD
Spread / Average Target
+26.60%
- Stock Market
- Certificates
- Certificat
